These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 17766372)
21. Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery. Murata M; Piao JS; Narahara S; Kawano T; Hamano N; Kang JH; Asai D; Ugawa R; Hashizume M Protein Expr Purif; 2015 Jun; 110():52-6. PubMed ID: 25497224 [TBL] [Abstract][Full Text] [Related]
22. Blocking peptides against HBV: preS1 protein selected from a phage display library. Wang W; Liu Y; Zu X; Jin R; Xiao G Biochem Biophys Res Commun; 2011 Sep; 412(4):633-7. PubMed ID: 21856287 [TBL] [Abstract][Full Text] [Related]
23. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity. Xu X; Li GD; Kong YY; Yang HL; Zhang Z; Cao HT; Wang Y J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840 [TBL] [Abstract][Full Text] [Related]
24. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041 [TBL] [Abstract][Full Text] [Related]
25. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. D'Mello F; Partidos CD; Steward MW; Howard CR Virology; 1997 Oct; 237(2):319-26. PubMed ID: 9356343 [TBL] [Abstract][Full Text] [Related]
26. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus. Zhang Q; Zhang X; Chen T; Wang X; Fu Y; Jin Y; Sun X; Gong T; Zhang Z Nanoscale; 2015; 7(20):9298-310. PubMed ID: 25945919 [TBL] [Abstract][Full Text] [Related]
27. Detection of hepatitis B virus PreS1 antigen using a time-resolved fluoroimmunoassay. Hu Z; Li M; Huang B; Liu J; Yu L; Chen G J Immunoassay Immunochem; 2012; 33(2):156-65. PubMed ID: 22471606 [TBL] [Abstract][Full Text] [Related]
28. Selection of HBV preS1-binding penta-peptides by phage display. He Y; Ye X; Tiollais P; Zhang J; Zhang J; Liu J; Xie Y Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):691-8. PubMed ID: 24966187 [TBL] [Abstract][Full Text] [Related]
29. Structure-antigenicity relationship of peptides from the pre-S2 region of the hepatitis B virus surface antigen. Lee MK; Kim KL; Hahm KS; Yang KH Biochem Mol Biol Int; 1994 Aug; 34(1):159-68. PubMed ID: 7531533 [TBL] [Abstract][Full Text] [Related]
30. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody. Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277 [TBL] [Abstract][Full Text] [Related]
31. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539 [TBL] [Abstract][Full Text] [Related]
32. Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus. Kang JH; Toita R; Asai D; Yamaoka T; Murata M J Virol Methods; 2014 Jun; 201():20-3. PubMed ID: 24568971 [TBL] [Abstract][Full Text] [Related]
33. [Correlations between preS1-antigen, HBV-DNA and HBV serum markers in patients with chronic hepatitis B]. Zhou H; Jiang CW; Qian JL; Li SJ; Liang JL; Chen XF Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1184-6. PubMed ID: 18676258 [TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation function of hepatitis B virus Pre S1 protein in yeast. Xiao SX; Peng XX; Chu YL; Xiao SB; Wu YH; Cao ZP Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):247-51. PubMed ID: 14599978 [TBL] [Abstract][Full Text] [Related]
35. [Antigenic analysis of two chimeric hepatitis B core particles presenting the preS1 neutralizing epitopes]. Su QD; Guo MZ; Yi Y; Chen SY; Jia ZY; Lu XX; Qiu F; Bi SL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):336-9. PubMed ID: 24645316 [TBL] [Abstract][Full Text] [Related]
36. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection. Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530 [TBL] [Abstract][Full Text] [Related]
37. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. Mun HS; Lee SA; Jee Y; Kim H; Park JH; Song BC; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Kook YH; Kim BJ J Med Virol; 2008 Jul; 80(7):1189-94. PubMed ID: 18461612 [TBL] [Abstract][Full Text] [Related]
38. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells. Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759 [TBL] [Abstract][Full Text] [Related]
39. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334 [TBL] [Abstract][Full Text] [Related]
40. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes. Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]